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The field of  nanomedicine holds vast potential for the 
improvement of  health care around the world and the coming 
nanomedical revolution will surely bring innovative solutions 
to many of  the difficulties we currently encounter in the realm 
of  patient treatment. Nanomedicine is a relatively new field for 
scientific inquiry. It is defined as the use of  nanoscale devices 
or materials to diagnose and cure diseases by actively interacting 
at the molecular level within a cellular system. In the context 
of  nanotechnology, the “molecular level” refers to structures 
less than 100 nanometers in diameter. Given the breadth of  
this definition of  nanomedicine, it can be narrowed and made 
more applicable when only those devices or medicines designed to 
function on the nanoscale are considered.
Nanorobotics, as its name suggests, is a discipline centered around 
robots constructed on the nanoscale. These robots could have 
many applications in the medical field and have the potential to 
drastically improve disease detection, drug delivery, immunization, 
and other forms of  treatment. An important area of  research is 
the development of  nanorobots that can detect cancerous cells 
and subsequently execute a targeted delivery of  cancer drugs. 
Current treatments such as chemotherapy indiscriminately attack 
all the cells in a given area and are therefore limited by the dosage 
of  the drug that the patient’s body can tolerate. In such cases, it 
is possible that this dosage will not succeed in entirely eliminating 
the cancer. The realization of  targeted drug delivery using 
nanorobots would allow us to apply the necessary amount of  a 
drug to a precise area without harming healthy tissue. In this way, 
nanorobots promise cancer treatments that are safer, less painful, 
and more effective than current treatments.
Researchers today are exploring organic, inorganic, and hybrid 
nanorobots. Organic nanorobots are based on adenosine 
triphosphate (ATP) and DNA molecular assembly and function. 
Another subset of  organic nanorobots, based on bacteria, have 
been proposed experimentally for drug delivery. Inorganic 
nanorobots are essentially nano-electromechanical systems 
(NEMS).  As technology has developed, some approaches have 
begun to combine both organic and inorganic elements, creating 
a more advanced robot system known as a hybrid nanosystem. 
The inherent programmability of  inorganic nanorobots based 
on CMOS technology makes them the most likely to succeed 
in performing the complex, precise tasks required of  medical 
nanorobots.
Some nanorobots currently being developed can detect cancerous 
cells by identifying biomarkers. There are currently a number of  
methods for identifying biomarkers.  One method involves the 
nanoscale cantilever, which resembles an everyday comb (at the 
nanoscale). This structure is coated with antibodies designed to 
bind molecules produced by cancer cells. Adsorption of  these 
molecules results in bending of  the cantilever, a change which 
can be measured by optical or electrical means and can therefore 
be used by researchers to verify the presence of  cancer. Other 
tools used to detect disease include nanowires, carbon nanotubes, 
quantum dots, and gold nanoparticles. These tools, like nanoscale 
cantilevers, are useful because they react in some measureable way 
to the presence of  certain molecules.
Nanorobots have great potential not only for the detection of  
cancer cells but also for their elimination. Some methods of  
nanorobotic cancer treatment currently being explored do not 
rely on the use of  traditional drugs. Gold nanoparticles and 
metal nanoshells can destroy cancerous tissues through thermal 
necrosis when they are heated through an external non-invasive 
heating source. Supermagnetic beads can penetrate and destroy 
cancer cells with the help of  an applied magnetic field. Magnetic 
fields also continue to be explored as a way of  directing the 
delivery of  medication in the body. Other researchers are studying 
the ability of  nanorobots to differentiate between normal and 
cancerous cells based on the presence of  surface antigens such 
as E-cadherin.
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In order for a treatment to be successful, nanorobots must 
be capable of  more than just detecting and eliminating cancer 
cells; they have to be able to withstand the sometimes extreme 
conditions within the human body long enough to travel to 
the cancerous cells and deliver the medication. Therefore, 
biocompatibility, the ability of  a material to perform with an 
appropriate host response in a specific situation, is extremely 
important in the development of  nanorobots. A nanorobot 
that is not fully biocompatible may trigger unwanted immune 
responses when introduced into the body. Stimulation of  the 
immune system, or immunostimulation, while sometimes desirable, 
can endanger the nanorobot, since it may be destroyed before 
it is able to complete its task. Immunostimulation can also be 
dangerous to the host, potentially inducing fever, inflammation, 
and hypersensitivity to allergens. Introducing a nanorobot into 
the body can also cause suppression of  the immune system, or 
immunosuppression. Immunosuppression can be helpful for the 
nanorobot since a weakened immune system is less able to attack 
foreign bodies. At the same time, however, a weakened immune 
system increases the patient’s vulnerability to viruses, bacteria, and 
infection. As nanorobots continue to improve, they will likely be 
most effective when they can enter the body without causing any 
disturbance of  the immune system. 
Although robots on the nanoscale are not yet being produced, 
we can use computer modeling to attempt to determine how 
various components will function once introduced into the 
body. Professor Eshaghian-Wilner’s research group has created 
a basic computer model in ExtendSim that can be used to study 
the performance and biocompatibility of  nanorobots and well as 
the toxicity of  different drugs. The model is in its early stages 
and currently lacks experimental data, but has been designed in 
such a way that new data can be added to the simulation fairly 
easily for future improvement.  Additional information regarding 
the current state of  nanomedicine as well as its potential for the 
future can be found in this research group’s recent publications 
[3-19].
As interest in nanomedicine builds, research institutions around 
the world are receiving increasing amounts of  funding to explore 
and innovate in such areas as nanorobotics. Ushering in the 
nanomedical revolution will undoubtedly prove essential in raising 
the level of  health care for people around the world.
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